Patient info Open main menu

Sprilon 12.5%w/w /1.04%w/w cutaneous spray, suspension – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
12.5%w/w /1.04%w/w
Contains active substances:

Patient leaflet - Sprilon 12.5%w/w /1.04%w/w cutaneous spray, suspension

1. WHAT SPRILON IS AND WHAT IT IS USED FOR

Sprilon contains Zinc Oxide and Dimeticone. Sprilon is used for the prevention and treatment of pressure sores, and skin damage from contact with body fluids, e. g. around the perineum, fistulae, colostomies, ileostomies, eczematous areas etc. It is also used for the protection and treatment of fissures and leg ulcers, and the protection of skin beneath plaster casts.

2. WHAT YOU NEED TO KNOW BEFORE YOU USE SPRILON

Do not use Sprilon and talk to your doctor if:

  • You are allergic to zinc oxide, dimeticone, wool fat or any of the other ingredients.
  • You are sensitive to cetostearyl alcohol.

Cetostearyl alcohol and wool fat may cause local skin reactions (e.g. contact dermatitis). Ask your doctor for advice before taking any medicine if you are pregnant or breast-feeding.

Warnings and precautions

Avoid inhalation or contact with the eyes. If condition is aggravated, discontinue use and consult doctor. Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.

3. HOW TO USE SPRILON For external use only.

Shake the can well. Hold the can 20cm (8”) away from the skin surface, at a right angle. Gently press the nozzle to apply a thin even layer. Two to three seconds of spraying should be sufficient to cover uk-pl-label Pg. 1 an area the size of the buttocks. A mild cooling sensation may be experienced. Re-apply as often as necessary.

Frequent, repeated application to the same area could lead to skin irritation. Other skin preparations may disrupt the Sprilon film if applied to the same area. If you accidentally spray into your eyes, bathe them thoroughly in water and talk to your doctor.

EXTREMELY FLAMMABLE

4. POSSIBLE SIDE EFFECTS

Like all medicines, Sprilon can cause side effects, although not everybody gets them. Stop use and talk to your doctor or pharmacist if:

  • You develop an allergic reaction (e.g. a rash)
  • You experience local skin irritation.
  • The condition becomes worse
  • Any side effect becomes more serious
  • You notice any side effect not listed

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE SPRILON Keep out of the sight and reach of children.

Do not store above 25°C. Replace the cap after use. Extremely flammable. The canister contains a pressurised liquid. Do not expose to temperature higher than 50°C, and do not pierce the canister. Do not use after expiry date shown on the base.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

The active substances are:

zinc oxide 12.5% w/w and dimeticone 1.04% w/w.

The other ingredients are:

white soft paraffin, wool fat, liquid paraffin, cetostearyl alcohol, wool alcohols, dextran CB and purified water.

The propellant is isobutane.

For information in large print, audio CD or braille please contact the Marketing Authorisation Holder.

This text was revised in May 2025.

uk-pl-label Pg. 2

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 60884/0001

Last revision stated in the text: May 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sprilon 12.5%w/w /1.04%w/w cutaneous spray, suspension

Active substances Dimeticone, Zinc oxide
Strength 12.5%w/w /1.04%w/w
Pharmaceutical form White, water-repellant, viscous ointment suspended in a propellant.
Excipients White soft paraffin, Wool fat (anhydrous lanolin), Liquid paraffin, Cetostearyl alcohol, Wool alcohols (wool wax alcohols), Dextran CB, Purified Water, Propellant: Isobutane
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Do not store above 25°C. Extremely flammable.
The canister contains a pressurised liquid. Do not expose to temperatures higher than 50°C. Do not pierce the canister.
Marketing authorisation PL 25298/0460 (first authorised 23 March 2005), PL 60884/0001
Marketing authorisation holder Brown & Burk UK Limited

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.